Compound Radar

Henry Schein, Inc. (HSIC) Stock Analysis

United States · Healthcare / Medical Distribution

Price $88.86
Market cap $9.90B
Next earnings Nov 3, 2026
Entry status Watch $76.75–$81.49

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

60
60/100 Good Quality
  • Financial Health 65
  • Profitability 50
  • Business Quality 60
  • Balance Sheet 40
  • Cash Flow 80

Why this rating?

Health 60/100 — Good Quality

Strongest Cash Flow 80/100
Softest Balance Sheet 40/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

Henry Schein, Inc. (HSIC) is a Medical Distribution company in the Healthcare sector. Compound Radar rates Henry Schein, Inc. 60/100 (Good Quality) due to solid business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 25.91
  • Forward P/E 14.81
  • PEG 1.79
  • EV/Revenue 1.12

Profitability

  • Revenue Growth 6.7%
  • Gross Margin 31.3%
  • Operating Margin 5.8%
  • Net Margin 3.0%
  • ROE 8.9%

Financial strength

  • Cash $157.00M
  • Debt $3.81B
  • Net Cash $-3.66B
  • Free Cash Flow $521.00M
  • Current Ratio 1.32

Similar companies

Peers in Medical Distribution, ranked by Financial Health.

View all in Medical Distribution →

FAQ

How Compound Radar scores and tracks Henry Schein, Inc. (HSIC).

View Methodology & FAQ →